INTRODUCTION AND OBJECTIVES: Lower urinary tract symptoms (LUTS) are a common complaint in aged males and usually have a major impact on their quality of life (QoL). overactive bladder (OAB) is one of the most bothering diseases in LUTS, and sometimes persists even after ordinary therapy, because of the unclear mechanism. On the other hand, metabolomics analysis enables the detection and semi-quantitative measurement of hundreds of unique metabolites from broad range of metabolic pathways, and these approaches can detect metabolites associated with pathophysiological states. In the present study, we identified metabolites from metabolomics approach and investigated association between these metabolites and urgency as a major complaint of OAB.
INTRODUCTION AND OBJECTIVES: Lower urinary tract symptoms (LUTS) are a common complaint in aged males and usually have a major impact on their quality of life (QoL). overactive bladder (OAB) is one of the most bothering diseases in LUTS, and sometimes persists even after ordinary therapy, because of the unclear mechanism. On the other hand, metabolomics analysis enables the detection and semi-quantitative measurement of hundreds of unique metabolites from broad range of metabolic pathways, and these approaches can detect metabolites associated with pathophysiological states. In the present study, we identified metabolites from metabolomics approach and investigated association between these metabolites and urgency as a major complaint of OAB.
METHODS: A total of 58 male participants without apparent neurological diseases at our outpatient clinic were enrolled in the present study. We checked the International Prostate Symptom Score (IPSS) and QOL score from them and divided the patients into two groups; Urgency-group (2 and more: n¼32), and Control-group (0 or 1: n¼26) in an urgency score of IPSS. Then, we conducted a comprehensive study of plasma metabolites using capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS). Metabolites were compared between Urgency-and Control-groups using MannWhitney U test, and biomarkers of OAB in males from metabolites in CE-TOFMS were analyzed using a multivariable logistic regression analysis.
RESULTS: The mean age was 71.5+/-4.3 years old, and the mean body mass index (BMI) was 23.0+/-2.7. Metabolomics analysis with CE-TOFMS identified 110 metabolites from plasma of participants. In a total of 11 metabolites, there was significant difference or a trend of difference between Urgency-and Control-groups. Regarding these 11 metabolites, a multivariate analysis showed that an increase of Glu and a decrease of Gln, Arg and IMP were associated with urgency in males.
CONCLUSIONS: From the present study, some metabolic pathways could be involved in incidence of OAB. Particularly, Glu, Gln and Arg are in the same metabolic pathway, and the pathway was associated with metabolic syndrome in the previous study. These metabolic changes may induce OAB, involving metabolic syndrome. Further studies using metabolomics analysis have a potential to detect new biomarkers and develop potential targets for new treatments.
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MP38-19 PROTEOMIC INVESTIGATION OF THE URINARY BIOMARKERS FOR INTERSTITAL CYSTITIS/BLADDER PAIN SYNDROME PATIENTS e MAPPING CHARACTERSTICS AND THE PREDICTION OF TREATMENT OUTCOME
Yuan-Hong Jiang*, Hann-Chorng Kuo, Hualien, Taiwan INTRODUCTION AND OBJECTIVES: Interstitial cystitis/ bladder pain syndrome (IC/BPS) is a chronic inflammatory disorder of urinary bladder with heterogeneous clinical characteristics. Cytokines and chemokines play crucial roles in the pathogenesis of IC/BPS. This study investigated the roles of urine biomarkers in diagnosis of IC/BPS with different characteristics, and in the prediction of treatment outcome.
METHODS: Urine samples were collected from 90 IC/BPS patients and 8 controls. Commercially available multiplex immunoassays (MILLIPLEXâmap kit) were used to analyse the targets of urine cytokines. Cytokines levels were compared among IC/BPS patients with different clinical characteristics. Cytokines levels at baseline were compared between the clinical responders (based on global response assessment increase of 2, and VAS of pain decrease of 2) and non-responders at 3 months after treatment.
RESULTS: IC/BPS patients with lower maximal bladder capacity (MBC) during cystoscopic hydrodistention had higher levels of urine cytokines (GM-CSF, MCP-1, VEGF, IFNg, IL-2, IL-13, and IL-15) than those with higher MBC (Table 1) . Also, IC/BPS patients with glomerulations had higher levels of urine cytokines (GM-CSF, VEGF, NGF, IL-2, and IL-4) than those without glomerulations. Urine GM-CSF, IFNg, IL-13, and IL-15 levels were negatively correlated with MBC, and urine IL-2 level was positively correlated with the grade of glomerulations (all p <0.05). Clinical responders after treatment had lower urine cytokines levels at baseline than non-responders. Different associated urinary cytokine profiles were noted based on different criteria of responders.
CONCLUSIONS: IC/ BPS patients with different clinical characteristics in bladder capacity and glomerulations had different urine cytokines levels. Baseline urine cytokines levels might be used for the prediction of treatment outcome of IC/ BPS.
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